NCT06754332View on ClinicalTrials.gov

The Study of Human Chorionic Gonadotropin (HCG) Activating the Dormant Follicles .

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

April 1, 2028

Study Completion Date

August 31, 2029

Conditions
Premature Ovarian Insufficiency
Interventions
DRUG

human chorionic gonadotropin

The POI patients receive a single intramuscular injection of 10,000 units of human chorionic gonadotropin.

All Listed Sponsors
lead

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

OTHER